Evaluation of antimicrobial susceptibility of enterobacteriaceae causing urinary tract infections in Africa

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 3628-3639

  Tansarli, Giannoula S ^a   Athanasiou, Stavros ^a,c   Falagas, Matthew E ^a,b,d  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b MITERA HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALOTIN; CEFIXIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN;

ADULT; AFRICA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITAL; HUMAN; KLEBSIELLA; MEDLINE; MULTICENTER STUDY; OUTPATIENT; PRIORITY JOURNAL; PROTEUS; PROTEUS VULGARIS; URINALYSIS; URINARY TRACT INFECTION; WORLD HEALTH ORGANIZATION;

AFRICA; AMIKACIN; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CROSS INFECTION; DATABASES, FACTUAL; DRUG EVALUATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FOSFOMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; URINARY TRACT INFECTIONS;

EID: 84880258962     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00359-13     Document Type: Article

References (46)

1. Butcu M, Akcay SS, Inan AS, Aksaray S, Engin DO, Calisici G. 2011. In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics. J. Infect. Chemother. 17:575-578.
2. Grude N, Tveten Y, Kristiansen BE. 2001. Urinary tract infections in Norway, bacterial etiology and susceptibility.Aretrospective study of clinical isolates. Clin. Microbiol. Infect. 7:543-547.
3. Gundogdu A, Long YB, Vollmerhausen TL, Katouli M. 2011. Antimicrobial resistance and distribution of sul genes and integron-associated intI genes among uropathogenic Escherichia coli in Queensland, Australia. J. Med. Microbiol. 60:1633-1642.
4. Ho PL, Wong RC, Yip KS, Loke SL, Leung MS, Mak GC, Chow FK, Tsang KW, Que TL. 2007. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women, emerging multidrug resistance phenotypes. Diagn. Microbiol. Infect. Dis. 59:439-445.
5. Kahlmeter G. 2000. The ECO. SENS Project, a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J. Antimicrob. Chemother. 46(Suppl. 1):15-22.
6. Lobel B, Valot A, Cattoir V, Lemenand O, Gaillot O. 2008. Comparison of antimicrobial susceptibility of 1,217 Escherichia coli isolates from women with hospital and community-acquired urinary tract infections. Presse Med. 37:746-750.
7. Maraki S, Samonis G, Rafailidis PI, Vouloumanou EK, Mavromanolakis E, Falagas ME. 2009. Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob. Agents Chemother. 53:4508-4510.
8. Schmiemann G, Gagyor I, Hummers-Pradier E, Bleidorn J. 2012. Resistance profiles of urinary tract infections in general practice-an observational study. BMC Urol. 12:33. doi:10.1186/1471-2490-12-33.
9. Shaifali I, Gupta U, Mahmood SE, Ahmed J. 2012. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. N Am. J. Med. Sci. 4:163-169.
10. Zhao L, Chen X, Zhu X, Yang W, Dong L, Xu X, Gao S, Liu X. 2009. Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China). Urology 74:702-707.
11. Bamford C, Bonorchis K, Ryan A, Hoffmann R, Naicker P, Maloba M, Nana T, Zietsman I, Govind C. 2012. Antimicrobial susceptibility patterns of Escherichia coli strains isolated from urine samples in South Africa from 2007-2011. S. Afr. J. Epidemiol. Infect. 27:46-52.
12. Iweriebor BC, Obi CL, Akinyemi O, Ramalivhana NJ, Hattori T, Okoh AI. 2012. Uropathogens isolated from HIV-infected patients from Limpopo Province, South Africa. Afr. J. Biotechnol. 11:10598-10604.
13. Ben Haj Khalifa A, Khedher M. 2012. Epidemiological study of Klebsiella spp. uropathogenic strains producing extended-spectrum beta-lactamase in a Tunisian university hospital, 2009. Pathol. Biol. (Paris) 60:e1-e5. doi: 10.1016/j.patbio.2010.11.003.
14. Larabi K, Masmoudi A, Fendri C. 2003. Bacteriological and susceptibility study of 1930 strains isolated from UTIs in a Tunis university hospital. Med. Mal. Infect. 33:348-352.
15. Smaoui H, Mahjoubi F, Boutiba I, Jouaihia W, Thabet L, Znazen A, Kammoun A, Mezghanni S, Triki O, Hammami A, Ben Hassen A, Kechrid A, Ben Redjeb S. 2003. Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000), a multicenter study. Tunis Med. 81:390-394.
16. Aboderin OA, Abdu AR, Odetoyin BW, Lamikanra A. 2009. Antimicrobial resistance in Escherichia coli strains from urinary tract infections. J. Natl. Med. Assoc. 101:1268-1273.
17. Abubakar E-MM. 2009. Antimicrobial susceptibility pattern of pathogenic bacteria causing urinary tract infections at the Specialist Hospital, Yola, Adamawa state, Nigeria. J. Clin. Med. Res. 1:001-008.
18. Dada-Adegbola HO, Muili KA. 2010. Antibiotic susceptibility pattern of urinary tract pathogens in Ibadan, Nigeria. Afr. J. Med. Med. Sci. 39:173-179.
19. Kehinde A, Adedapo K, Aimakhu C, Odukogbe AT, Olayemi O, Salako B. 2012. Urinary pathogens and drug susceptibility patterns of urinary tract infections among antenatal clinic attendees in Ibadan, Nigeria. J. Obstet. Gynaecol. Res. 38:280-284.
20. Nwadioha SI, Nwokedi EE, Jombo GTA, Kashibu E, Alao OO. 2010. Antimicrobial susceptibility pattern of uropathogenic bacterial isolates from community-and hospital-acquired urinary tract infections in a Nigerian tertiary hospital. Internet J. Infect. Dis. 8:1. doi:10.5580/14f7.
21. Nwanze PI, Nwaru LM, Oranusi S, Dimkpa U, Okwu MU, Babatunde BB, Anake TA, Jatto W, Asagwara CE. 2007. Urinary tract infection in Okada village, prevalence and antimicrobial susceptibility pattern. Sci. Res. Essays 2:112-116.
22. Okesola AO, Aroundegbe TI. 2011. Antibiotic resistance pattern of uropathogenic Escherichia coli in South West Nigeria. Afr. J. Med. Med. Sci. 40:235-238.
23. Soge OO, Queenan AM, Ojo KK, Adeniyi BA, Roberts MC. 2006. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae. J. Antimicrob. Chemother. 57:24-30.
24. Dromigny JA, Nabeth P, Juergens-Behr A, Perrier-Gros-Claude JD. 2005. Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal. J. Antimicrob. Chemother. 56:236-239.
25. Dromigny JA, Nabeth P, Perrier Gros Claude JD. 2002. Distribution and susceptibility of bacterial urinary tract infections in Dakar, Senegal. Int. J. Antimicrob. Agents 20:339-347.
26. Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA, Gaye-Diallo A, Guyomard S, Seck A, Breurec S, Garin B. 2007. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J. Infect. Dev. Ctries. 1:263-268.
27. Bourjilat F, Bouchrif B, Dersi N, Claude JD, Amarouch H, Timinouni M. 2011. Emergence of extended-spectrum beta-lactamases-producing Escherichia coli in community-acquired urinary infections in Casablanca, Morocco. J. Infect. Dev. Ctries. 5:850-855.
28. Bouzenoune F, Boudersa F, Bensaad A, Harkat F, Siad N. 2009. Urinary tract infections in Ain M'lila (Algeria). Antibiotic resistance of 239 strains isolated between 2006 and 2007. Med. Mal. Infect. 39:142-143.
29. Ghenghesh KS, Elkateb E, Berbash N, Abdel Nada R, Ahmed SF, Rahouma A, Seif-Enasser N, Elkhabroun MA, Belresh T, Klena JD. 2009. Uropathogens from diabetic patients in Libya, virulence factors and phylogenetic groups of Escherichia coli isolates. J. Med. Microbiol. 58: 1006-1014.
30. Kariuki S, Revathi G, Corkill J, Kiiru J, Mwituria J, Mirza N, Hart CA. 2007. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams. J. Infect. Dev. Ctries. 1:257-262.
31. Mbanga J, Dube S, Munyanduki H. 2010. Prevalence and drug resistance in bacteria of the urinary tract infections in Bulawayo Province, Zimbabwe. East Afr. J. Public Health 7:229-232.
32. Muvunyi CM, Masaisa F, Bayingana C, Mutesa L, Musemakweri A, Muhirwa G, Claeys GW. 2011. Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda, need for new antimicrobial guidelines. Am. J. Trop. Med. Hyg. 84:923-928.
33. Bercion R, Mossoro-Kpinde D, Manirakiza A, Le Faou A. 2009. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African Republic. J. Infect. Dev. Ctries. 3:187-190.
34. Hima-Lerible H, Menard D, Talarmin A. 2003. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Bangui, Central African Republic. J. Antimicrob. Chemother. 51:192-194.
35. Nadmi H, Elotmani F, Talmi M, Zerouali K, Perrier-Gros-Claude JD, Timinouni M. 2010. Antibiotic resistance profile of community acquired uropathogenic enterobacteria in El Jadida (Morocco). Med. Mal. Infect. 40:303-305.
36. Randrianirina F, Soares JL, Carod JF, Ratsima E, Thonnier V, Combe P, Grosjean P, Talarmin A. 2007. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J. Antimicrob. Chemother. 59:309-312.
37. Ahmed AA, Osman H, Mansour AM, Musa HA, Ahmed AB, Karrar Z, Hassan HS. 2000. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Am. J. Trop. Med. Hyg. 63:259-263.
38. Issack MI, Yee Kin Tet HY, Morlat P. 2007. Antimicrobial resistance among enterobacteriaceae causing uncomplicated urinary tract infections in Mauritius, consequences of past misuse of antibiotics. J. Chemother. 19:222-225.
39. Acharya A, Gautam R, Subedee L. 2011. Uropathogens and their antimicrobial susceptibility pattern in Bharatpur, Nepal. Nepal Med. Coll. J. 13:30-33.
40. Akram M, Shahid M, Khan AU. 2007. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections inJNMCHospital Aligarh, India. Ann. Clin. Microbiol. Antimicrob. 6:4.
41. Hussain A, Ewers C, Nandanwar N, Guenther S, Jadhav S, Wieler LH, Ahmed N. 2012. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic, genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-beta-lactamase-producing lineage. Antimicrob. Agents Chemother. 56:6358-6365.
42. Sood S, Gupta R. 2012. Antibiotic resistance pattern of community acquired uropathogens at a tertiary care hospital in Jaipur, Rajasthan. Indian J. Community Med. 37:39-44.
43. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. 2010. Fosfomycin for the treatment of multidrug-resistant, including extendedspectrum beta-lactamase producing, Enterobacteriaceae infections, a systematic review. Lancet Infect. Dis. 10:43-50.
44. Daza R, Gutierrez J, Piedrola G. 2001. Antibiotic susceptibility of bac-terial strains isolated from patients with community-acquired urinary tract infections. Int. J. Antimicrob. Agents 18:211-215.
45. Goldstein FW. 2000. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre study group. Eur. J. Clin. Microbiol. Infect. Dis. 19: 112-117.
46. Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, Hawser S. 2012. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum betalactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe, results from the SMART study 2009-2010. Diagn. Microbiol. Infect. Dis. 74:62-67.